Hematology/Oncology

Top Story

Higher total body irradiation dose fails to improve transplant outcomes in non-Hodgkin lymphoma

Higher total body irradiation dose fails to improve transplant outcomes in non-Hodgkin lymphoma
February 19, 2020
In the Journals

CAR-T confers long-term quality-of-life improvement among patients with advanced lymphoma

February 19, 2020
Patients with relapsed or refractory diffuse large B-cell lymphoma experienced clinically meaningful improvements in long-term quality-of-life measurements after…
FDA News

FDA grants breakthrough therapy designation to Padcev regimen for advanced bladder cancer

February 19, 2020
The FDA granted breakthrough therapy designation to enfortumab vedotin-ejfv in combination with pembrolizumab for the treatment of patients with unresectable locally…
FDA News

FDA grants priority review to Tecentriq for first-line treatment of advanced non-small cell lung cancer

February 19, 2020
The FDA granted priority review to atezolizumab monotherapy as first-line treatment for patients with advanced nonsquamous or squamous non-small cell lung cancer without…
Meeting News

Novel small-molecule inhibitor ‘quite promising’ in advanced kidney cancer

February 18, 2020
MK-6482 appeared well-tolerated and showed promising single-agent activity among heavily pretreated patients with clear cell renal cell carcinoma, according to results…
More Headlines »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next